AIGH Capital Management LLC Has $8.56 Million Stock Holdings in Elutia Inc. (NASDAQ:ELUT)

AIGH Capital Management LLC raised its stake in shares of Elutia Inc. (NASDAQ:ELUT - Free Report) by 10.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,381,415 shares of the company's stock after purchasing an additional 306,740 shares during the period. Elutia accounts for approximately 3.5% of AIGH Capital Management LLC's investment portfolio, making the stock its 8th biggest position. AIGH Capital Management LLC owned approximately 8.30% of Elutia worth $8,555,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of ELUT. Silverarc Capital Management LLC raised its position in Elutia by 8.3% during the 4th quarter. Silverarc Capital Management LLC now owns 1,782,271 shares of the company's stock worth $6,666,000 after purchasing an additional 136,463 shares during the last quarter. Northern Trust Corp raised its position in Elutia by 30.0% during the 4th quarter. Northern Trust Corp now owns 17,957 shares of the company's stock worth $67,000 after purchasing an additional 4,148 shares during the last quarter. 683 Capital Management LLC bought a new position in Elutia during the 4th quarter worth $302,000. Citadel Advisors LLC bought a new position in Elutia during the 4th quarter worth $84,000. Finally, Millennium Management LLC raised its position in shares of Elutia by 16.4% in the 4th quarter. Millennium Management LLC now owns 45,217 shares of the company's stock worth $169,000 after acquiring an additional 6,386 shares in the last quarter. 74.03% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Lake Street Capital lowered their price objective on Elutia from $10.00 to $8.00 and set a "buy" rating for the company in a research report on Friday, May 9th.

Elutia Stock Performance

Shares of ELUT stock traded up $0.07 during mid-day trading on Tuesday, hitting $2.20. The company's stock had a trading volume of 5,923 shares, compared to its average volume of 40,138. Elutia Inc. has a 52 week low of $1.61 and a 52 week high of $5.12. The company has a market cap of $90.25 million, a PE ratio of -1.14 and a beta of 0.88. The company's fifty day simple moving average is $1.91 and its 200-day simple moving average is $2.47.

Elutia (NASDAQ:ELUT - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.01). The company had revenue of $6.03 million during the quarter, compared to analyst estimates of $6.65 million. On average, equities analysts anticipate that Elutia Inc. will post -1.74 earnings per share for the current year.

Elutia Profile

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.